Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,495 | 60 | 71.1% |
| Education | $407.73 | 14 | 19.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 9.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $727.28 | 26 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $504.80 | 19 | $0 (2024) |
| Vifor Pharma, Inc. | $319.95 | 6 | $0 (2024) |
| Amgen Inc. | $186.40 | 10 | $0 (2020) |
| Mallinckrodt Hospital Products Inc. | $121.73 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $65.82 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $41.72 | 2 | $0 (2018) |
| Relypsa, Inc. | $35.25 | 2 | $0 (2019) |
| Fresenius USA Marketing, Inc. | $28.24 | 2 | $0 (2019) |
| Horizon Therapeutics plc | $26.64 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $241.81 | 11 | AstraZeneca Pharmaceuticals LP ($63.61) |
| 2023 | $563.04 | 17 | AstraZeneca Pharmaceuticals LP ($238.55) |
| 2022 | $288.10 | 7 | AstraZeneca Pharmaceuticals LP ($212.64) |
| 2021 | $415.53 | 10 | Vifor Pharma, Inc. ($200.00) |
| 2020 | $197.21 | 9 | OPKO Pharmaceuticals, LLC ($104.13) |
| 2019 | $244.87 | 13 | OPKO Pharmaceuticals, LLC ($84.09) |
| 2018 | $113.46 | 6 | Amgen Inc. ($71.74) |
| 2017 | $39.01 | 2 | Amgen Inc. ($39.01) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Hyperkalemia | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $33.37 | General |
| 10/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Hyperkalemia | ||||||
| 10/14/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $23.39 | General |
| Category: NEPHROLOGY | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/11/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $22.02 | General |
| Category: NEPHROLOGY | ||||||
| 02/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: DIABETES | ||||||
| 02/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $21.77 | General |
| Category: NEPHROLOGY | ||||||
| 10/30/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.45 | General |
| 10/19/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 06/22/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $22.09 | General |
| Category: NEPHROLOGY | ||||||
| 06/22/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $1.13 | General |
| Category: NEPHROLOGY | ||||||
| 06/14/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: IMMUNOLOGY | ||||||
| 05/26/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $61.99 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/27/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $30.80 | General |
| Category: NEPHROLOGY | ||||||
| 04/19/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Hyperkalemia | ||||||
| 03/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $55.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 218 | 484 | $166,072 | $76,151 |
| 2022 | 8 | 181 | 498 | $186,060 | $94,606 |
| 2021 | 7 | 188 | 560 | $230,273 | $120,424 |
| 2020 | 10 | 339 | 878 | $294,637 | $125,536 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 23 | 135 | $81,000 | $39,407 | 48.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 134 | $22,512 | $9,605 | 42.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 20 | 28 | $15,456 | $7,062 | 45.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 56 | $13,664 | $6,036 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 28 | $5,600 | $3,055 | 54.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 25 | $8,000 | $2,963 | 37.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 18 | $8,496 | $2,826 | 33.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 23 | 34 | $5,644 | $2,185 | 38.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,600 | $1,846 | 51.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 14 | $2,100 | $1,167 | 55.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 26 | 213 | $127,800 | $70,229 | 55.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 66 | $16,104 | $6,303 | 39.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 78 | $13,488 | $4,392 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 47 | $7,050 | $3,630 | 51.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 25 | $5,000 | $2,909 | 58.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 22 | $7,040 | $2,802 | 39.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 22 | 34 | $5,678 | $2,295 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,900 | $2,047 | 52.5% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 36 | 285 | $171,000 | $95,522 | 55.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 109 | $18,344 | $7,405 | 40.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 62 | $15,159 | $6,043 | 39.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 29 | $5,800 | $3,341 | 57.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 23 | $7,360 | $2,980 | 40.5% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 25 | 39 | $6,474 | $2,671 | 41.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $6,136 | $2,463 | 40.1% |
About Dr. Michael Goldman, M.D
Dr. Michael Goldman, M.D is a Internal Medicine healthcare provider based in Kew Gardens, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2010. The National Provider Identifier (NPI) number assigned to this provider is 1912220666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Goldman, M.D has received a total of $2,103 in payments from pharmaceutical and medical device companies, with $241.81 received in 2024. These payments were reported across 75 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,495).
As a Medicare-enrolled provider, Goldman has provided services to 926 Medicare beneficiaries, totaling 2,420 services with total Medicare billing of $416,717. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Kew Gardens, NY
- Active Since 03/09/2010
- Last Updated 12/05/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1912220666
Products in Payments
- RAYALDEE (Drug) $420.71
- LOKELMA (Drug) $355.28
- Veltassa (Drug) $355.20
- FARXIGA (Drug) $353.63
- Parsabiv (Biological) $148.08
- ACTHAR (Biological) $121.73
- Rayaldee (Drug) $84.09
- JYNARQUE (Drug) $41.72
- Parsabiv (Drug) $38.32
- Velphoro (Drug) $28.24
- KRYSTEXXA (Biological) $26.64
- JARDIANCE (Drug) $25.08
- Kcentra (Biological) $20.12
- BRILINTA (Drug) $18.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kew Gardens
Avneet Singh, Md, MD
Internal Medicine — Payments: $14,211
Dr. Billa Fisher Rados, Md, MD
Internal Medicine — Payments: $1,535
Dr. Karen Wong, M.d, M.D
Internal Medicine — Payments: $445.07
Dr. Danil Rafailov, Md, MD
Internal Medicine — Payments: $244.87
Allen Small, M.d, M.D
Internal Medicine — Payments: $172.76